{"filing":{"accession":"0001780649-26-000014","url":"/filing/0001780649-26-000014","form_type":"4","issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_name_source":null,"issuer_ticker":"ADPT","issuer_url":"/issuer/0001478320","period_of_report":"2026-08-17","filed_date":"2026-08-19","acceptance_dt":"2026-08-19T20:15:10+00:00","acceptance_label":"2026-08-19 20:15 UTC","ingested_at":"2026-08-20T05:22:56.381658+00:00","ingested_label":"2026-08-20 05:22 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1478320/0001780649-26-000014-index.htm","day_url":"/filings/2026-08-19"},"owners":[{"owner_cik":"0001780649","owner_name":"ROBINS CHAD M","url":"/insider/0001780649","anchor":"owner-0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","is_director":true,"is_officer":true,"is_ten_percent":false,"is_other":false,"filing_anchor":"/filing/0001780649-26-000014#owner-0001780649"}],"line_owners":[{"owner_name":"ROBINS CHAD M","role":"Director, Officer (CEO and Chairman)"}],"transactions":[{"id":9298908,"accession":"0001780649-26-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780649-26-000014","line_url":"/filing/0001780649-26-000014#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_display_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318799.0,"shares_display":"318,799","price_per_share":25.08,"price_display":"25.08","price_state":"stated","total_value":7995478.92,"total_display":"7,995,478.92","total_whole":"7,995,479","shares_owned_after":2183043.0,"shares_owned_after_display":"2,183,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298909,"accession":"0001780649-26-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780649-26-000014","line_url":"/filing/0001780649-26-000014#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_display_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2525.0,"shares_display":"2,525","price_per_share":25.57,"price_display":"25.57","price_state":"stated","total_value":64564.25,"total_display":"64,564.25","total_whole":"64,564","shares_owned_after":2180518.0,"shares_owned_after_display":"2,180,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298910,"accession":"0001780649-26-000014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001780649-26-000014","line_url":"/filing/0001780649-26-000014#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_display_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":278472.0,"shares_display":"278,472","price_per_share":24.48,"price_display":"24.48","price_state":"stated","total_value":6816994.56,"total_display":"6,816,994.56","total_whole":"6,816,995","shares_owned_after":2180722.0,"shares_owned_after_display":"2,180,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298911,"accession":"0001780649-26-000014","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001780649-26-000014","line_url":"/filing/0001780649-26-000014#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_display_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":204.0,"shares_display":"204","price_per_share":25.14,"price_display":"25.14","price_state":"stated","total_value":5128.56,"total_display":"5,128.56","total_whole":"5,129","shares_owned_after":2180518.0,"shares_owned_after_display":"2,180,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":4,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-08-20T05:22:56.381658+00:00","retrieved_label":"2026-08-20 05:22 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1478320/0001780649-26-000014-index.htm","accepted_at":"2026-08-19T20:15:10+00:00","accepted_label":"2026-08-19 20:15 UTC"},"related":[{"accession":"0001237566-26-000003","url":"/filing/0001237566-26-000003","form_type":"4","issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_name_source":null,"issuer_ticker":"ADPT","issuer_url":"/issuer/0001478320","period_of_report":"2026-08-17","filed_date":"2026-08-19","acceptance_dt":"2026-08-19T20:07:56+00:00","acceptance_label":"2026-08-19 20:07 UTC","ingested_at":"2026-08-20T05:22:56.381658+00:00","ingested_label":"2026-08-20 05:22 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1478320/0001237566-26-000003-index.htm","day_url":"/filings/2026-08-19"}],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001780649-26-000014","retrieved_at":"2026-08-27T08:54:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}